{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:54:32Z","timestamp":1790704472505,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Government of the Russian Federation","award":["14.W03.31.0009"],"award-info":[{"award-number":["14.W03.31.0009"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clim.2018.12.010","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T14:00:52Z","timestamp":1544450452000},"page":"44-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Relapsing Evans syndrome and systemic lupus erythematosus with antiphospholipid syndrome treated with Bortezomib in combination with plasma exchange"],"prefix":"10.1016","volume":"199","author":[{"given":"Olga","family":"Tkachenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Lapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Maslyansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Myachikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Mikhailova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Gilburd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.12.010_bb0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2018.12.010_bb0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.48.5.362","article-title":"Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder","volume":"48","author":"Mackworth-Young","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.12.010_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0961203307087876","article-title":"Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up","volume":"17","author":"Ruckert","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2018.12.010_bb0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2009-09-242917","article-title":"Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib","volume":"115","author":"Carson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.12.010_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/rheumatology\/keu393","article-title":"Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient","volume":"54","author":"Wang","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2018.12.010_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.blre.2015.05.001","article-title":"Lyse or not to lyse: clinical significance of red blood cell autoantibodies","volume":"29","author":"Meulenbroek","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.clim.2018.12.010_bb0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2018.12.010_bb0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/nep.12527","article-title":"Emerging therapies in immunoglobulin A nephropathy","volume":"20","author":"Yeo","year":"2015","journal-title":"Nephrology"},{"key":"10.1016\/j.clim.2018.12.010_bb0045","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.12.010_bb0050","article-title":"The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis","volume":"096120331668670","author":"Zhang","year":"2017","journal-title":"Lupus"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618307204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618307204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T21:01:29Z","timestamp":1552597289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618307204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":10,"alternative-id":["S1521661618307204"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.12.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapsing Evans syndrome and systemic lupus erythematosus with antiphospholipid syndrome treated with Bortezomib in combination with plasma exchange","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}